To UW-Madison stem-cell scientist Clive Svendsen, a bill the U.S. House of Representative is set to vote on today would allow him to study more diseases.
To Beth Donley, the bill to lift restrictions on federal funding for embryonic stem-cell research would reduce expenses at her new stem-cell company in Madison.
To James Thomson, the bill would mean the country has gotten over the ethical quandary he ignited when he first isolated the cells here nine years ago.